Timothy M. Mayleben - 13 May 2021 Form 3 Insider Report for Landos Biopharma, Inc.

Role: Director
Signature: /s/ Eric W. Blanchard, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 13 May 2021
Net transactions value: $0
Form type: 3
Filing time: 17 May 2021, 17:56:51 UTC
Next filing: 21 Dec 2021
SEC: View on sec.gov

No securities are beneficially owned.